- Home
- CLDI vs SDOT Comparison
CLDI vs SDOT Comparison
Compare CLDI & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDI | SDOT |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 4.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLDI | SDOT |
|---|---|---|
| Price | $0.30 | $2.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 265.3K | 26.9K |
| Earning Date | 03-16-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 490.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,929,137.00 |
| Revenue This Year | N/A | $12.76 |
| Revenue Next Year | N/A | $5.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.08 |
| 52 Week Low | $0.22 | $0.72 |
| 52 Week High | $7.32 | $13.02 |
Technical Indicators
Market Signals| Indicator | CLDI | SDOT |
|---|---|---|
| Relative Strength Index (RSI) | 18.85 | 39.77 |
| Support Level | $0.22 | $1.18 |
| Resistance Level | $0.90 | $2.40 |
| Average True Range (ATR) | 0.04 | 0.24 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 0.04 | 47.45 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.